C07K 14/79
Transferrins
Official title: Transferrins, e.g. lactoferrins, ovotransferrins
C07K14/79 (Transferrins) appears on 375 US grants and 527 published applications in this corpus.
Search patents in C07K- Granted patents
- 375
- Published applications
- 527
- Assignees
- 291
- Inventors
- 1,030
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 3 | 0 |
| 1994 | 8 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 8 | 0 |
| 1998 | 15 | 0 |
| 1999 | 15 | 0 |
| 2000 | 15 | 0 |
| 2001 | 13 | 3 |
| 2002 | 8 | 14 |
| 2003 | 4 | 19 |
| 2004 | 3 | 16 |
| 2005 | 7 | 10 |
| 2006 | 12 | 15 |
| 2007 | 12 | 10 |
| 2008 | 9 | 14 |
| 2009 | 5 | 18 |
| 2010 | 7 | 13 |
| 2011 | 10 | 19 |
| 2012 | 12 | 12 |
| 2013 | 6 | 15 |
| 2014 | 10 | 18 |
| 2015 | 14 | 18 |
| 2016 | 18 | 21 |
| 2017 | 15 | 14 |
| 2018 | 10 | 27 |
| 2019 | 17 | 26 |
| 2020 | 15 | 29 |
| 2021 | 23 | 28 |
| 2022 | 13 | 15 |
| 2023 | 12 | 28 |
| 2024 | 10 | 33 |
| 2025 | 8 | 38 |
| 2026 | 5 | 54 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tumor-targeting, clearable human protein-based MRI nanoprobes, and compositions and methods thereof12 May 2026US 12,622,983 B2University of Massachusetts
- Methods for improving leptin sensitivity for the treatment of obesity and diabetes24 Mar 2026US 12,582,702 B2University of Massachusetts
- Compositions and methods for treatment and prevention of Alzheimer's disease24 Mar 2026US 12,583,920 B2The General Hospital Corporation
- Ferritin nanocage for multi-displaying trail trimer and cancer-targeting peptide and use thereof as anticancer agent17 Mar 2026US 12,577,292 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Targeted expression of microbial cholesterol catalysis genes reduces excess lipid10 Feb 2026US 12,544,402 B2Repair Biotechnologies, Inc.
- Peptide Having Affinity for Human Transferrin Receptor24 Sep 2026US 2026/0285942 A1JCR Pharmaceuticals Co., Ltd.
- Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes3 Sep 2026US 2026/0256888 A1University of Massachusetts
- Protein complex and production process thereof6 Aug 2026US 2026/0226418 A1Darwin Biotechnology (Hubei) Co., Ltd.
- Affinity-based methods for using transferrin receptor-binding proteins9 Jul 2026US 2026/0191935 A1Denali Therapeutics Inc.
- Production of proteins, including secreted proteins26 Mar 2026US 2026/0085107 A1Ginkgo Bioworks, Inc.
Most cited
By later US patents
- Methods and materials for making and using transgenic dicamba-degrading organisms1,215US 8,629,323 B2Board of Regents of the University of Nebraska · 2014
- Methods and materials for making and using transgenic dicamba-degrading organisms1,214US 7,812,224 B2Board of Regents of the University of Nebraska · 2010
- Methods and materials for making and using transgenic dicamba-degrading organisms1,208US 8,119,380 B2Board of Regents of the University of Nebraska · 2012
- Affinity binding-based system for detecting particulates in a fluid268US 6,143,247 AGamera Bioscience Corporation · 2000
- Transgenic bovine266US 5,741,957 APharming B.V. · 1998